Lipid Profile Evolution in Graves’ Disease Treated with Titration Regimen of Anti-Thyroid Drugs Versus Block and Replace Regimen
Hormone and Metabolic Research · 01.10.2024 · 56 (10) · 712-717
DOI: 10.1055/a-2281-0911 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.10.2024. Verfasst von Ana-Maria Stancu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medicine, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. Hauptthemen laut MEDLINE: Graves Disease, Antithyroid Agents, Lipids. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
The aim was to compare the lipid profile of patients with GD treated with anti-thyroid drugs (ATDs) using a titration regimen versus a block and replace regimen. This is an 18-month prospective observational study. In this study were included 149 medically treated GD patients, aged+>+18 years. Pregnant women and patients treated with radioactive iodine therapy or partial/total thyroidectomy were excluded. Patients were divided into 2 subgroups: titration (A) and block and replace (B) therapy, according to the ATD regimen used. Thyroid and metabolic profile was measured at baseline and at least one visit during medical treatment. The whole group included 122 (81.87%) females (F) and 27 (18.12%) males (M), ratio F:M=4.5:1. As expected, at the time of diagnosis, thyrotoxic patients were with normal lipid profile. During medical treatment, in patients who achieved euthyroidism, the cholesterol levels increased as follows: in subgroup A: by 52.9 mg/dl (95% CI: 26.4–79.3), p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medicine, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
- Endocrinology IV, "C.I. Parhon" National Institute of Endocrinology, Bucharest, Romania.
- Research Department, "C.I. Parhon" National Institute of Endocrinology, Bucharest, Romania.
ORCID-Profile: Ana-Maria Stancu
Zitieren
APA
Stancu, A. M., Pop, O., Purice, M., & Badiu, C. (2024). Lipid Profile Evolution in Graves’ Disease Treated with Titration Regimen of Anti-Thyroid Drugs Versus Block and Replace Regimen. Hormone and Metabolic Research, 56(10), 712-717. https://doi.org/10.1055/a-2281-0911
Vancouver
Stancu AM, Pop O, Purice M, Badiu C. Lipid Profile Evolution in Graves’ Disease Treated with Titration Regimen of Anti-Thyroid Drugs Versus Block and Replace Regimen. Hormone and Metabolic Research. 2024;56(10):712-717. doi:10.1055/a-2281-0911
BibTeX
@article{Stancu2024,
author = {Stancu, Ana-Maria and Pop, Oana and Purice, Mariana and Badiu, Corin},
title = {Lipid Profile Evolution in Graves’ Disease Treated with Titration Regimen of Anti-Thyroid Drugs Versus Block and Replace Regimen},
journal = {Hormone and Metabolic Research},
year = {2024},
volume = {56},
number = {10},
pages = {712--717},
doi = {10.1055/a-2281-0911}
}
EUVIMED